With the expansion of immunotherapy indications for cancer treatment in New Zealand, immune-related adverse events are expected to increase.
Te Pūao Mātai Pukupuku NZSO Oncology Immunotoxicity Webinar Series has been developed to support New Zealand health professionals in identifying, managing, and understanding immunotherapy toxicities and contraindications.
This free educational series will bring together leading national and international experts to provide practical, evidence-based guidance for professionals involved in cancer care.
Join our webinar mailing list to receive future updates about this series, including details of the first event in the coming month. Please note this is separate from the NZSO database.
We encourage you to share this information widely within your networks and circulate the promotional poster among your communities and colleagues.
If you have questions around this webinar series, please contact:
Georgia Watson
Conference Innovators
georgia@conference.nz
+64 3 352 8120
Upcoming Webinar | 11 June
Oncology Immunotherapy: Key Concepts and Practical Pearls for Primary and Emergency Clinicians
Thursday 11 June | 7.00 – 8.30pm
Presented by Dr Gareth Rivalland | Medical Oncologist, Auckland
Oncology immunotherapy has transformed outcomes for many cancer patients, but unlike traditional chemotherapy, it can produce unique immune-related adverse effects that often present first in primary care and emergency settings. This session will provide a practical overview of immunotherapy, outline common toxicities, and highlight key strategies for early recognition, assessment, and initial management.
Introducing
Dr Gareth Rivalland
Gareth is a Medical Oncologist, specialising in the treatment of melanoma/skin and thoracic cancers, at both Harbour Cancer & Wellness and Auckland City Hospital, where he is the Melanoma team lead. He has been the Principal investigator in numerous Phase 1 to 3 global clinical trials.